Target intelligence / Profile preview

U6 small nuclear RNA 1 (RNU6-1)

Target
RNU6-1
Molecular classification
small nuclear RNA, non-coding RNA, spliceosomal RNA
01

Overview

U6 small nuclear RNA 1 (RNU6-1) is a non-coding RNA that forms a catalytic core component of the spliceosome, the molecular machine responsible for the removal of introns from pre-messenger RNA (pre-mRNA) in eukaryotic cells[2][3]. U6 snRNA is highly conserved across species, reflecting its essential role in gene expression and cell viability[2][3][4]. It is transcribed by RNA polymerase III and, in humans, is approximately 107 nucleotides long[5][7]. U6 snRNA undergoes complex biogenesis and structural rearrangements to interact with multiple spliceosomal proteins and other small nuclear RNAs (such as U4 and U2), coordinating the two-step splicing chemistry necessary for intron excision[2][3]. While U6 RNA has been employed as an internal control in molecular assays (such as RT-qPCR), recent studies indicate its expression can be highly variable between tissues and disease states, questioning its suitability as a normalization reference[1]. U6 does not function as a drug target, enzyme, receptor, or transporter, but its proper biogenesis and function are critical for normal RNA processing and, by extension, normal cellular function[2][6].

Other names
RNU6AU6U6-1RNU6RNA, U6A small nuclear
02

Biological functions

Pre-mRNA splicingRNA processingSpliceosome assembly
03

Disease associations

Used as a reference gene in cancer researchVariability linked to cancer-related pathways
04

Biomarkers

Has been used as a normalization control in qPCR for miRNA expression, but expression varies and its reliability as a biomarker is under debate[1].

Beyond the preview

Go deeper on U6 small nuclear RNA 1 (RNU6-1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on U6 small nuclear RNA 1 (RNU6-1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call